Why MongoDB Stock Is Moving Lower Friday
MongoDB, Inc. (NASDAQ: MDB) shares are trading lower Friday after the company issued weak guidance for the upcoming quarter as well as fiscal-year 2025.
What’s Going On With Nikola Stock Friday?
The Russell 3000 index has begun its 2024 Reconstitution process, and Nikola Corporation is on the preliminary list of index deletions. If the deletion of Nikola proceeds, the company will be removed from the index as of the end of trading on June 28, 2024.
Summit Therapeutics’ Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck’s Multi-Billion Keytruda In China Study
Summit Therapeutics shares dropped 27.3% to $7.94 in premarket trading Friday after a 272.1% surge on Thursday. The company announced Phase 3 HARMONi-2 trial results, where ivonescimab significantly improved progression-free survival in NSCLC patients compared to Keytruda.
Why Veeva Systems Shares Are Diving Friday
Veeva Systems' Q1 FY25 results beat expectations with 24% revenue growth and $1.50 EPS, but lowered outlook for revenue.
Why Branded Footwear Retailer Genesco’s Shares Are Shooting Higher Today
Genesco shares surge as Q1 FY25 earnings beat estimates. Sales dropped 5.3% to $457.60M, surpassing the expected $445.05M. CEO Mimi E. Vaughn credits strategic execution amid challenges. Fiscal 2025 EPS outlook reaffirmed at $0.60 - $1.00.
What’s Going On With Sports Betting And Gambling Company Flutter Entertainment On Friday?
Flutter Entertainment Plc (NYSE: FLUT) announced CFO's departure & replacement by Rob Coldrake. Shift to US market faces challenges, but reports strong growth in revenue, EBITDA & EPS. FLUT stock down 4% in last 12 months. Investors can access industry through ESPO & HERO ETFs. FLUT down 2.47% premarket at $183.25.
BRP Down Over 3% After Q1 Earnings – Here’s Why
BRP revises FY25 guidance downward, citing challenges in dealer profitability and macroeconomic conditions.
Gilead’s Trodelvy Fails To Hit Primary Goal In Late-Stage Study With Most Common Type Of Bladder Cancer
Gilead Sciences' announced topline results from the Phase 3 TROPiCS-04 study on Trodelvy for metastatic urothelial cancer. The study did not meet the primary endpoint of overall survival but showed numerical improvements favoring Trodelvy.
Faraday Future Stock Rebounds After 91% Crash In 8 Days; CEO Addresses ‘Misperceptions,’ Discusses ‘Overcoming Short Selling’
Faraday Future's stock rebounds 13.3% after 91% crash. CEO reassures investors about dilution & bankruptcy risks. Plans strategic update in 1-2 months.
Why V.F. Corporation Shares Are Rising Today
V.F. Corporation shares are rising in premarket trading following the announcement of Michelle Choe's appointment as Global Brand President of Vans, signaling potential growth and brand enhancement under her leadership.